The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
(S)-3-Hydroxy-2-oxo-1-phenylpyrrolidine-3-carboxylic Acid 3,5-Difluorobenzylamide ID: ALA4558399
PubChem CID: 56960816
Max Phase: Preclinical
Molecular Formula: C18H16F2N2O3
Molecular Weight: 346.33
Molecule Type: Unknown
Associated Items:
Names and Identifiers Canonical SMILES: O=C(NCc1cc(F)cc(F)c1)[C@@]1(O)CCN(c2ccccc2)C1=O
Standard InChI: InChI=1S/C18H16F2N2O3/c19-13-8-12(9-14(20)10-13)11-21-16(23)18(25)6-7-22(17(18)24)15-4-2-1-3-5-15/h1-5,8-10,25H,6-7,11H2,(H,21,23)/t18-/m0/s1
Standard InChI Key: QCMLCNXMSHSKMM-SFHVURJKSA-N
Molfile:
RDKit 2D
25 27 0 0 0 0 0 0 0 0999 V2000
27.6694 -4.3158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.4692 -4.5324 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2569 -3.7315 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1845 -7.0402 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.1834 -7.8674 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8980 -8.2802 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6143 -7.8669 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.6114 -7.0366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8962 -6.6275 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.8879 -5.8017 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
29.5537 -5.3149 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2965 -4.5312 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.2191 -5.3189 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.4355 -5.5762 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
28.8417 -3.1498 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.4608 -3.5158 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
29.6379 -3.3654 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.2227 -2.7837 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.0184 -3.0017 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.6029 -2.4208 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.3917 -1.6225 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.5908 -1.4083 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0097 -1.9907 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.3989 -2.6368 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
30.3766 -0.6119 0.0000 F 0 0 0 0 0 0 0 0 0 0 0 0
2 1 1 0
2 3 1 1
4 5 2 0
5 6 1 0
6 7 2 0
7 8 1 0
8 9 2 0
9 4 1 0
10 11 1 0
11 12 1 0
12 2 1 0
2 13 1 0
13 10 1 0
9 10 1 0
13 14 2 0
3 15 1 0
3 16 2 0
15 17 1 0
17 18 1 0
18 19 2 0
19 20 1 0
20 21 2 0
21 22 1 0
22 23 2 0
23 18 1 0
20 24 1 0
22 25 1 0
M END Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 346.33Molecular Weight (Monoisotopic): 346.1129AlogP: 1.75#Rotatable Bonds: 4Polar Surface Area: 69.64Molecular Species: NEUTRALHBA: 3HBD: 2#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 2#RO5 Violations (Lipinski): ┄CX Acidic pKa: 10.76CX Basic pKa: ┄CX LogP: 1.64CX LogD: 1.64Aromatic Rings: 2Heavy Atoms: 25QED Weighted: 0.83Np Likeness Score: -0.93
References 1. Heinrich T, Seenisamy J, Blume B, Bomke J, Calderini M, Eckert U, Friese-Hamim M, Kohl R, Lehmann M, Leuthner B, Musil D, Rohdich F, Zenke FT.. (2019) Discovery and Structure-Based Optimization of Next-Generation Reversible Methionine Aminopeptidase-2 (MetAP-2) Inhibitors., 62 (10): [PMID:30939017 ] [10.1021/acs.jmedchem.9b00041 ]